Commission Regulation (EU) 2019/831
of 22 May 2019
amending Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products1, and in particular Article 15(1), the fourth subparagraph of Article 15(2) and Article 31(1) thereof,
Whereas:
Regulation (EC) No 1272/2008 of the European Parliament and of the Council2 provides for a harmonised classification of substances as carcinogenic, mutagenic or toxic for reproduction (CMR) based on a scientific assessment by the Risk Assessment Committee of the European Chemicals Agency. The substances are classified as CMR substances of category 1A, CMR substances of category 1B or CMR substances of category 2 depending on the level of evidence of their CMR properties.
Article 15 of Regulation (EC) No 1223/2009 provides that substances which have been classified as CMR substances of category 1A, category 1B or category 2 under Part 3 of Annex VI to Regulation (EC) No 1272/2008 (CMR substances) are prohibited from use in cosmetic products. A CMR substance may however be used in cosmetic products where the conditions laid down in the second sentence of Article 15(1) or in the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009 are fulfilled. This Regulation implements Regulation (EC) No 1223/2009. Only the Court of Justice of the European Union is entitled to interpret Union law, including Article 15 of Regulation (EC) No 1223/2009.
In order to uniformly implement the prohibition of CMR substances within the internal market, to ensure legal certainty, in particular for economic operators and national competent authorities and to ensure a high level of protection of human health, all CMR substances should be included in the list of prohibited substances in Annex II to Regulation (EC) No 1223/2009 and, where relevant, deleted from the lists of restricted or authorised substances in Annexes III and V to that Regulation. Where the conditions laid down in the second sentence of Article 15(1) or the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009 are fulfilled, the lists of restricted or authorised substances in Annexes III and V to that Regulation should be amended accordingly.
This Regulation covers the substances which have been classified as CMR substances pursuant to Regulation (EC) No 1272/2008 as at 1 December 2018, when Commission Regulation (EU) 2017/7763 became applicable.
Concerning certain CMR substances for which a request for use in cosmetic products by way of exception has been submitted, it has not been established that all the conditions provided for in the second sentence of Article 15(1) or the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009 are fulfilled. This concerns Quaternium-15, Chloroacetamide, Dichloromethane, Formaldehyde, Perboric acid and Sodium perborate compounds
The substance Methenamine 3-chloroallylochloride, with the International Nomenclature of Cosmetic Ingredients (INCI) name Quaternium-15, is currently listed in entry 31 of Annex V to Regulation (EC) No 1223/2009 as allowed in a concentration of up to 0,2 % in ready for use preparation. Quaternium-15 is a mixture of cis and trans isomers of which the cis-isomer has been classified as a CMR substance of category 2 by Commission Regulation (EC) No 790/20094. The classification became applicable on 1 December 2010. In accordance with the second sentence of Article 15(1) of Regulation (EC) No 1223/2009, a substance classified in category 2 may be used in cosmetic products where the substance has been evaluated by the Scientific Committee on Consumer Safety (SCCS) and found safe for use in cosmetic products. On 13 and 14 December 2011, the SCCS issued a scientific opinion on Quaternium-15 (cis-isomer)5, which concluded that on the basis of the available data the safety of Quaternium-15 for use in cosmetic products cannot be established. In light of the classification of the cis-isomer present in Quaternium-15 as a CMR substance of category 2 and the opinion of the SCCS, Quaternium-15 should be deleted from the list of preservatives allowed in cosmetic products in Annex V to Regulation (EC) No 1223/2009 and added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.
The substance 2-Chloroacetamide, with the INCI name Chloroacetamide, is currently listed in entry 41 of Annex V to Regulation (EC) No 1223/2009 as allowed in a concentration of up to 0,3 % in ready for use preparation. Chloroacetamide has been classified as a CMR substance of category 2 under Regulation (EC) No 1272/2008. The classification became applicable before 1 December 2010, at which date Titles II, III and IV of Regulation (EC) No 1272/2008 became applicable in respect of substances. In accordance with the second sentence of Article 15(1) of Regulation (EC) No 1223/2009, a substance classified in category 2 may be used in cosmetic products where the substance has been evaluated by the SCCS and found safe for use in such products. On 22 March 2011, the SCCS issued a scientific opinion on Chloroacetamide6 which concluded that, on the basis of the available data, the substance is not safe for consumers when used in a concentration of up to 0,3 % w/w in cosmetic products. In light of the classification as a CMR substance of category 2 and the opinion of the SCCS, Chloroacetamide should be deleted from the list of preservatives allowed in cosmetic products in Annex V to Regulation (EC) No 1223/2009 and added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.
The substance Dichloromethane is currently listed in entry 7 of Annex III to Regulation (EC) No 1223/2009 as allowed in cosmetic products in a concentration of up to 35 % in ready for use preparation. Dichloromethane has been classified as a CMR substance of category 2 under Regulation (EC) No 1272/2008. The classification became applicable before 1 December 2010. In accordance with the second sentence of Article 15(1) of Regulation (EC) No 1223/2009, a substance classified in category 2 may be used in cosmetic products where the substance has been evaluated by the SCCS and found safe for use in such products. On 11 December 2012, the SCCS issued a scientific opinion on Dichloromethane7. On 25 March 2015, the SCCS issued a new opinion8 which was revised on 28 October 2015. In that revised opinion the SCCS concluded that the use of Dichloromethane in a concentration of up to 35 % in hair sprays and its use in spray formulations in general is not considered safe for the consumer. In light of the classification as a CMR substance of category 2 and the opinion of the SCCS, and since no other uses of Dichloromethane in cosmetic products are known and have been covered by the SCCS opinion, the substance should be deleted from the list of restricted substances in Annex III to Regulation (EC) No 1223/2009 and added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.
The substance Formaldehyde is currently listed in entry 13 of Annex III to Regulation (EC) No 1223/2009 as allowed in nail hardening products in a concentration of up to 5 % in ready for use preparation. It is also currently listed in entry 5 of Annex V to Regulation (EC) No 1223/2009 as allowed in oral products in a concentration of up to 0,1 % and in other products in a concentration of up to 0,2 %. Formaldehyde has been classified as a CMR substance of category 1B by Commission Regulation (EU) No 605/20149. The classification became applicable on 1 January 2016. In accordance with the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009, substances classified as CMR substances of category 1A or 1B may be used in cosmetic products by way of exception where, subsequent to their classification as CMR substances, certain conditions are fulfilled, including the conditions that no suitable alternative substances are available, that an application is made for a particular use of the product category with a known exposure and that the substance has been evaluated and found safe by the SCCS. On 7 November 2014, the SCCS concluded in its opinion10 that ‘nail hardeners with a maximum concentration of about 2,2 % free formaldehyde can be used safely to harden or strengthen nails’. However, since it has not been established that there are no suitable alternative substances available for the purpose of hardening nails, Formaldehyde should be deleted from the list of restricted substances in Annex III to Regulation (EC) No 1223/2009. Since no application was made for other uses of Formaldehyde, the substance should be deleted from the list of preservatives allowed in cosmetic products in Annex V to that Regulation. Formaldehyde should also be added to the list of substances prohibited in cosmetic products in Annex II to Regulation (EC) No 1223/2009.
Perboric acid and Sodium perborate compounds are covered by the hydrogen peroxide releasing substances currently listed in entry 12 of Annex III to Regulation (EC) No 1223/2009. They have been classified as CMR substances of category 1B by Regulation (EC) No 790/2009. The classification became applicable by 1 December 2010. A request for the application of the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009 was submitted for the use of those substances in oxidative hair dye formulations. On 22 June 2010, the SCCS concluded in its opinion11 that the ‘general restrictions applicable to hydrogen peroxide releasing substances should apply to sodium perborate and perboric acid and that the use of sodium perborates as an ingredient in oxidative hair dye formulations with a maximum on-head concentration of 3 % will not pose a risk to the health of the consumer’. However, since it has not been established that there are no suitable alternative substances available for the purpose of oxidation of hair, Perboric acid and Sodium perborate compounds should be deleted from the list of restricted substances in Annex III to Regulation (EC) No 1223/2009 and added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.
Concerning certain substances which were classified as CMR substances under Regulation (EC) No 1272/2008 and for which a request for the application of the second sentence of Article 15(1) of Regulation (EC) No 1223/2009 has been submitted, it has been established that the condition provided for in that provision is fulfilled. This concerns Trimethylbenzoyl diphenylphosphine oxide, Furfural and Polyaminopropyl biguanide.
The substance Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide, with the INCI name Trimethylbenzoyl diphenylphosphine oxide (TPO), is currently not included in the Annexes to Regulation (EC) No 1223/2009. TPO has been classified as a CMR substance of category 2 by Commission Regulation (EU) No 618/201212. The classification became applicable on 1 December 2013. On 27 March 2014, the SCCS issued a scientific opinion13 which concluded that TPO is safe when used as a nail modelling product in a concentration of up to 5,0 % but that it is however a moderate skin sensitizer. Considering the skin sensitising properties of TPO and the high risk of exposure through skin contact in case of self-application of nail products, the use of TPO should be restricted to professionals only. In light of those elements, TPO should be added to the list of restricted substances in Annex III to Regulation (EC) No 1223/2009 for professional use in artificial nail systems with a maximum concentration of 5 %.
The substance 2-Furaldehyde, with the INCI name Furfural, is used as a fragrance or flavour ingredient in cosmetic products and is currently not included in the Annexes to Regulation (EC) No 1223/2009. It has been classified as a CMR substance of category 2 under Regulation (EC) No 1272/2008. The classification became applicable before 1 December 2010. On 27 March 2012, the SCCS concluded in its opinion14 that the use of Furfural in a concentration of up to 10 ppm (0,001 %) in ready for use preparation, including oral products, does not pose any risk to the health of the consumer. In light of the classification of Furfural as a CMR substance of category 2 and the opinion of the SCCS, Furfural should be added to the list of restricted substances in Annex III to Regulation (EC) No 1223/2009 with a maximum concentration of 0,001 %.
The substance Polyhexamethylene biguanide hydrochloride (PHMB), with the INCI name Polyaminopropyl Biguanide, is currently listed as a preservative in entry 28 of Annex V to Regulation (EC) No 1223/2009 with a maximum concentration of 0,3 %. It has been classified as a CMR substance of category 2 by Commission Regulation (EU) No 944/201315. The classification became applicable on 1 January 2015. On 18 June 2014, the SCCS adopted an opinion16 which concluded that on the basis of the data available, PHMB is not safe for consumers when used as a preservative in all cosmetic products at a maximum concentration of 0,3 %. However, the SCCS opinion also concluded that the safe use could be based on a lower use concentration and/or restrictions with regard to cosmetic products' categories and that dermal absorption studies on additional representative cosmetic formulations are needed. On 7 April 2017, the SCCS adopted a new opinion17 which concluded that, based on the data provided, the use of PHMB as a preservative in all cosmetic products up to 0,1 % is safe but that its use in sprayable formulations is not advised. In light of the classification of PHMB as a CMR substance of category 2 and of the new SCCS opinion, PHMB should be authorised as a preservative in all cosmetic products, except in applications that may lead to exposure of the end-user's lungs by inhalation, with a maximum concentration of 0,1 %. The conditions set out in Annex V to Regulation (EC) No 1223/2009 should be adapted accordingly.
Concerning a large group of substances which were classified as CMR substances under Regulation (EC) No 1272/2008, no request for use in cosmetic products by way of exception has been submitted. Those substances should be included in the list of prohibited substances in Annex II to Regulation (EC) No 1223/2009 and, where relevant, deleted from the lists of restricted or authorised substances in Annexes III and V to that Regulation. This concerns, inter alia, some boron compounds currently listed in entries 1a and 1b of Annex III to Regulation (EC) No 1223/2009.
Some boron compounds currently listed in entries 1a and 1b of Annex III to Regulation (EC) No 1223/2009 and Dibutyltin hydrogen borate have been classified as CMR substances of category 1B by Regulation (EC) No 790/2009. The classification became applicable by 1 December 2010. In accordance with the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009, substances classified as CMR substances of category 1A or 1B may be used in cosmetic products by way of exception where, subsequent to their classification as CMR substances, certain conditions are fulfilled. On 22 June 2010, the SCCS issued an opinion18 which concluded that some of the boron compounds currently listed in entries 1a and 1b of Annex III to that Regulation are safe for use in cosmetics under certain conditions. However, since no application for a particular use was made and since it has not been established that there are no suitable alternative substances available for the purpose of the relevant uses listed in Annex III to Regulation (EC) No 1223/2009, those boron compounds should be deleted from the list of restricted substances in Annex III to that Regulation and added to the list of substances prohibited in cosmetic products in Annex II to Regulation (EC) No 1223/2009. As regards Dibutyltin hydrogen borate, no application for a particular use was made and it has not been found safe by the SCCS. That substance should therefore be added to the list of substances prohibited in cosmetic products in Annex II to Regulation (EC) No 1223/2009.
Article 31(1) of Regulation (EC) No 1223/2009 provides that where there is a potential risk to human health, arising from the use of substances in cosmetic products, which needs to be addressed on a Community-wide basis, the Commission may, after consulting the SCCS, amend Annexes II to VI to that Regulation accordingly. The Commission has consulted the SCCS on the safety of certain substances which are similar from a chemical perspective to substances classified as CMR substances of categories 1A, 1B or 2. This concerns certain boron compounds as well as Paraformaldehyde and Methylene Glycol.
Certain boron compounds currently listed in entries 1a and 1b of Annex III to Regulation (EC) No 1223/2009, other than those referred to in Recital 16, have not been classified as CMR substances. On 12 December 2013, the SCCS issued an opinion on borates, tetraborates and octaborates19, where it concluded that those substances, as well as other boric acid salts or esters, such as MEA-borate, MIPA-borate, potassium borate, trioctyldodecyl borate and zinc borate, form boric acid in aqueous solutions and that therefore the general restrictions applicable to boric acid should apply to the whole group of borates, tetraborates and octaborates. Boric acid has been classified as a CMR substance of category 1B by Regulation (EC) No 790/2009. The classification became applicable by 1 December 2010. In light of the opinion of the SCCS, the whole group of borates, tetraborates and octaborates, except the substances in that group that have been classified as CMR substances, as well as other boric acid salts or esters, should be deleted from the list of restricted substances in Annex III to Regulation (EC) No 1223/2009 and added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.
The substance Paraformaldehyde is currently listed in entry 5 of Annex V to Regulation (EC) No 1223/2009 but, contrary to Formaldehyde, it has not been classified as a CMR substance. The substance Methylene Glycol is currently not included in the Annexes to Regulation (EC) No 1223/2009. On 26–27 June 2012, the SCCS adopted an opinion on Methylene Glycol20 which established that Methylene Glycol is rapidly reversible under a variety of conditions to form Formaldehyde in aqueous solutions and that Paraformaldehyde can depolymerise to form Formaldehyde by heating or drying. In light of the opinion of the SCCS, there is a potential risk to human health arising from the use of those substances in cosmetic products. Paraformaldehyde should therefore be deleted from the list of preservatives allowed in cosmetic products in Annex V to Regulation (EC) No 1223/2009 and Paraformaldehyde and Methylene Glycol should be added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.
Regulation (EC) No 1223/2009 should therefore be amended accordingly.
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Cosmetic Products,
HAS ADOPTED THIS REGULATION:
Article 1
Annexes II, III and V to Regulation (EC) No 1223/2009 are amended in accordance with the Annex to this Regulation.
Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 22 May 2019.
For the Commission
The President
Jean-Claude Juncker
ANNEX
(1)Annex II is amended as follows:
- (a)
the following entries are added:
Reference number
Substance identification
Chemical name/INN
CAS number
EC number
a
b
c
d
‘1385
Cis-1-(3-chloroallyl)-3,5,7- triaza-1-azoniaadamantane chloride (cis-CTAC)
51229-78-8
426-020-3
1386
Cis-1-(3-chlorallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis-CTAC), quaternium-15
51229-78-8
426-020-3
1387
2-Chloracetamide
79-07-2
201-174-2
1388
Octamethylcyclotetrasiloxane
556-67-2
209-136-7
1389
Dichloromethane; methylene chloride
75-09-2
200-838-9
1390
2,2′-((3,3′,5,5′-Tetramethyl-(1,1′-biphenyl)-4,4′-diyl)-bis(oxymethylene))-bis-oxirane
85954-11-6
413-900-7
1391
Acetaldehyde; ethanal
75-07-0
200-836-8
1392
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
93107-30-3
413-760-7
1393
N-Methyl-2-pyrrolidone; 1-methyl-2-pyrrolidone
872-50-4
212-828-1
1394
Diboron trioxide; boric oxide
1303-86-2
215-125-8
1395
Boric acid [1]
Boric acid [2]
10043-35-3 [1]
11113-50-1 [2]
233-139-2 [1]
234-343-4 [2]
1396
Borates, tetraborates, octaborates and boric acid salts and esters, including:
Disodium octaborate tetrahydrate [1]
12280-03-4 [1]
234-541-0 [1]
2-Aminoethanol, monoester with boric acid [2]
10377-81-8 [2]
233-829-3 [2]
2-Hydroxypropyl ammonium dihydrogen orthoborate [3]
68003-13-4 [3]
268-109-8 [3]
Potassium borate, boric acid potassium salt [4]
12712-38-8 [4]
603-184-6 [4]
Trioctyldodecyl borate [5]
[5]
— [5]
Zinc borate [6]
1332-07-6 [6]
215-566-6 [6]
Sodium borate, disodium tetraborate anhydrous; boric acid, sodium salt [7]
1330-43-4 [7]
215-540-4 [7]
Tetraboron disodium heptaoxide, hydrate [8]
12267-73-1 [8]
235-541-3 [8]
Orthoboric acid, sodium salt [9]
13840-56-7 [9]
237-560-2 [9]
Disodium tetraborate decahydrate; borax decahydrate [10]
1303-96-4 [10]
215-540-4 [10]
Disodium tetraborate pentahydrate; borax pentahydrate [11]
12179-04-3 [11]
215-540-4 [11]
1397
Sodium perborate [1]
Sodium peroxometaborate; sodium peroxoborate [2]
15120-21-5 [1]
239-172-9 [1]
7632-04-4 [2]
10332-33-9 [2]
10486-00-7[2]
231-556-4 [2]
1398
Perboric acid (H3BO2(O2)), monosodium salt trihydrate [1]
13517-20-9 [1]
239-172-9 [1]
Perboric acid, sodium salt, tetrahydrate [2]
37244-98-7 [2]
234-390-0 [2]
Perboric acid (HBO(O2)), sodium salt, tetrahydrate sodium peroxoborate hexahydrate [3]
10486-00-7 [3]
231-556-4 [3]
1399
Perboric acid, sodium salt [1]
11138-47-9 [1]
234-390-0 [1]
Perboric acid, sodium salt, monohydrate [2]
12040-72-1 [2]
234-390-0 [2]
Perboric acid (HBO(O2)), sodium salt, monohydrate [3]
10332-33-9 [3]
231-556-4 [3]
1400
Dibutyltin hydrogen borate
75113-37-0
401-040-5
1401
Nickel bis(tetrafluoroborate)
14708-14-6
238-753-4
1402
Mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt
8018-01-7
616-995-5
1403
Maneb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric)
12427-38-2
235-654-8
1404
Benfuracarb (ISO); ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate
82560-54-1
617-356-3
1405
O-Isobutyl-N-ethoxy carbonylthiocarbamate
103122-66-3
434-350-4
1406
Chlorpropham (ISO); isopropyl 3-chlorocarbanilate
101-21-3
202-925-7
1407
O-Hexyl-N-ethoxycarbonylthiocarbamate
109202-58-6
432-750-3
1408
Hydroxylammonium nitrate
13465-08-2
236-691-2
1409
(4-Ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane
105024-66-6
405-020-7
1410
Phoxim (ISO); α-(diethoxy-phosphinothioylimino) phenylacetonitrile
14816-18-3
238-887-3
1411
Glufosinate ammonium (ISO); ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate
77182-82-2
278-636-5
1412
Reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate
—
435-960-3
1413
(4-Phenylbutyl)phosphinic acid
86552-32-1
420-450-5
1414
Reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol
170016-25-8
427-050-1
1415
Potassium titanium oxide (K2Ti6O13)
12056-51-8
432-240-0
1416
Cobalt di(acetate)
71-48-7
200-755-8
1417
Cobalt dinitrate
10141-05-6
233-402-1
1418
Cobalt carbonate
513-79-1
208-169-4
1419
Nickel dichloride
7718-54-9
231-743-0
1420
Nickel dinitrate [1]
13138-45-9 [1]
236-068-5 [1]
Nitric acid, nickel salt [2]
14216-75-2 [2]
238-076-4 [2]
1421
Nickel matte
69012-50-6
273-749-6
1422
Slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate
92129-57-2
295-859-3
1423
Slimes and sludges, copper electrolyte refining, decopperised
94551-87-8
305-433-1
1424
Nickel diperchlorate; perchloric acid, nickel(II) salt
13637-71-3
237-124-1
1425
Nickel dipotassium bis(sulfate) [1]
13842-46-1 [1]
237-563-9 [1]
Diammonium nickel bis(sulfate) [2]
15699-18-0 [2]
239-793-2 [2]
1426
Nickel bis(sulfamidate); nickel sulfamate
13770-89-3
237-396-1
1427
Nickel bis(tetrafluoroborate)
14708-14-6
238-753-4
1428
Nickel diformate [1]
3349-06-2 [1]
222-101-0 [1]
Formic acid, nickel salt [2]
15843-02-4 [2]
239-946-6 [2]
Formic acid, copper nickel salt [3]
68134-59-8 [3]
268-755-0 [3]
1429
Nickel di(acetate) [1]
373-02-4 [1]
206-761-7 [1]
Nickel acetate [2]
14998-37-9 [2]
239-086-1 [2]
1430
Nickel dibenzoate
553-71-9
209-046-8
1431
Nickel bis(4-cyclohexylbutyrate)
3906-55-6
223-463-2
1432
Nickel(II) stearate; nickel(II) octadecanoate
2223-95-2
218-744-1
1433
Nickel dilactate
16039-61-5
—
1434
Nickel(II) octanoate
4995-91-9
225-656-7
1435
Nickel difluoride [1]
10028-18-9 [1]
233-071-3 [1]
Nickel dibromide [2]
13462-88-9 [2]
236-665-0 [2]
Nickel diiodide [3]
13462-90-3 [3]
236-666-6 [3]
Nickel potassium fluoride [4]
11132-10-8 [4]
— [4]
1436
Nickel hexafluorosilicate
26043-11-8
247-430-7
1437
Nickel selenate
15060-62-5
239-125-2
1438
Nickel hydrogen phosphate [1]
14332-34-4 [1]
238-278-2 [1]
Nickel bis(dihydrogen phosphate) [2]
18718-11-1 [2]
242-522-3 [2]
Trinickel bis(orthophosphate) [3]
10381-36-9 [3]
233-844-5 [3]
Dinickel diphosphate [4]
14448-18-1 [4]
238-426-6 [4]
Nickel bis(phosphinate) [5]
14507-36-9 [5]
238-511-8 [5]
Nickel phosphinate [6]
36026-88-7 [6]
252-840-4 [6]
Phosphoric acid, calcium nickel salt [7]
17169-61-8 [7]
— [7]
Diphosphoric acid, nickel(II) salt [8]
19372-20-4 [8]
— [8]
1439
Diammonium nickel hexacyanoferrate
74195-78-1
—
1440
Nickel dicyanide
557-19-7
209-160-8
1441
Nickel chromate
14721-18-7
238-766-5
1442
Nickel(II) silicate [1]
21784-78-1 [1]
244-578-4 [1]
Dinickel orthosilicate [2]
13775-54-7 [2]
237-411-1 [2]
Nickel silicate (3:4) [3]
31748-25-1 [3]
250-788-7 [3]
Silicic acid, nickel salt [4]
37321-15-6 [4]
253-461-7 [4]
Trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]
12519-85-6 [5]
235-688-3 [5]
1443
Dinickel hexacyanoferrate
14874-78-3
238-946-3
1444
Trinickel bis(arsenate); nickel(II) arsenate
13477-70-8
236-771-7
1445
Nickel oxalate [1]
547-67-1 [1]
208-933-7 [1]
Oxalic acid, nickel salt [2]
20543-06-0 [2]
243-867-2 [2]
1446
Nickel telluride
12142-88-0
235-260-6
1447
Trinickel tetrasulfide
12137-12-1
—
1448
Trinickel bis(arsenite)
74646-29-0
—
1449
Cobalt nickel gray periclase; C.I. Pigment Black 25; C.I. 77332 [1]
68186-89-0 [1]
269-051-6 [1]
Cobalt nickel dioxide [2]
58591-45-0 [2]
261-346-8 [2]
Cobalt nickel oxide [3]
12737-30-3 [3]
620-395-9 [3]
1450
Nickel tin trioxide; nickel stannate
12035-38-0
234-824-9
1451
Nickel triuranium decaoxide
15780-33-3
239-876-6
1452
Nickel dithiocyanate
13689-92-4
237-205-1
1453
Nickel dichromate
15586-38-6
239-646-5
1454
Nickel(II) selenite
10101-96-9
233-263-7
1455
Nickel selenide
1314-05-2
215-216-2
1456
Silicic acid, lead nickel salt
68130-19-8
—
1457
Nickel diarsenide [1]
12068-61-0 [1]
235-103-1 [1]
Nickel arsenide [2]
27016-75-7 [2]
248-169-1 [2]
1458
Nickel barium titanium primrose priderite; C.I. Pigment Yellow 157; C.I. 77900
68610-24-2
271-853-6
1459
Nickel dichlorate [1]
67952-43-6 [1]
267-897-0 [1]
Nickel dibromate [2]
14550-87-9 [2]
238-596-1 [2]
Ethyl hydrogen sulfate, nickel(II) salt [3]
71720-48-4 [3]
275-897-7 [3]
1460
Nickel(II) trifluoroacetate [1]
16083-14-0 [1]
240-235-8 [1]
Nickel(II) propionate [2]
3349-08-4 [2]
222-102-6 [2]
Nickel bis(benzenesulfonate) [3]
39819-65-3 [3]
254-642-3 [3]
Nickel(II) hydrogen citrate [4]
18721-51-2 [4]
242-533-3 [4]
Citric acid, ammonium nickel salt [5]
18283-82-4 [5]
242-161-1 [5]
Citric acid, nickel salt [6]
22605-92-1 [6]
245-119-0 [6]
Nickel bis(2-ethylhexanoate) [7]
4454-16-4 [7]
224-699-9 [7]
2-Ethylhexanoic acid, nickel salt [8]
7580-31-6 [8]
231-480-1 [8]
Dimethylhexanoic acid, nickel salt [9]
93983-68-7 [9]
301-323-2 [9]
Nickel(II) isooctanoate [10]
29317-63-3 [10]
249-555-2 [10]
Nickel isooctanoate [11]
27637-46-3 [11]
248-585-3 [11]
Nickel bis(isononanoate) [12]
84852-37-9 [12]
284-349-6 [12]
Nickel(II) neononanoate [13]
93920-10-6 [13]
300-094-6 [13]
Nickel(II) isodecanoate [14]
85508-43-6 [14]
287-468-1 [14]
Nickel(II) neodecanoate [15]
85508-44-7 [15]
287-469-7 [15]
Neodecanoic acid, nickel salt [16]
51818-56-5 [16]
257-447-1 [16]
Nickel(II) neoundecanoate [17]
93920-09-3 [17]
300-093-0 [17]
Bis(d.-gluconato-O1,O2)nickel [18]
71957-07-8 [18]
276-205-6 [18]
Nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2) [19]
52625-25-9 [19]
258-051-1 [19]
Nickel(II) palmitate [20]
13654-40-5 [20]
237-138-8 [20]
(2-Ethylhexanoato-O)(isononanoato-O)nickel [21]
85508-45-8 [21]
287-470-2 [21]
(Isononanoato-O)(isooctanoato-O)nickel [22]
85508-46-9 [22]
287-471-8 [22]
(Isooctanoato-O)(neodecanoato-O)nickel [23]
84852-35-7 [23]
284-347-5 [23]
(2-Ethylhexanoato-O)(isodecanoato-O)nickel [24]
84852-39-1 [24]
284-351-7 [24]
(2-Ethylhexanoato-O)(neodecanoato-O)nickel [25]
85135-77-9 [25]
285-698-7 [25]
(Isodecanoato-O)(isooctanoato-O)nickel [26]
85166-19-4 [26]
285-909-2 [26]
(Isodecanoato-O)(isononanoato-O)nickel [27]
84852-36-8 [27]
284-348-0 [27]
(Isononanoato-O)(neodecanoato-O)nickel [28]
85551-28-6 [28]
287-592-6 [28]
Fatty acids, C6-19-branched, nickel salts [29]
91697-41-5 [29]
294-302-1 [29]
Fatty acids, C8-18 and C18-unsaturated, nickel salts [30]
84776-45-4 [30]
283-972-0 [30]
2,7-Naphthalenedisulfonic acid, nickel(II) salt [31]
72319-19-8 [31]
[31]
1461
Nickel(II) sulfite [1]
7757-95-1 [1]
231-827-7 [1]
Nickel tellurium trioxide [2]
15851-52-2 [2]
239-967-0 [2]
Nickel tellurium tetraoxide [3]
15852-21-8 [3]
239-974-9 [3]
Molybdenum nickel hydroxide oxide phosphate [4]
68130-36-9 [4]
268-585-7 [4]
1462
Nickel boride (NiB) [1]
12007-00-0 [1]
234-493-0 [1]
Dinickel boride [2]
12007-01-1 [2]
234-494-6 [2]
Trinickel boride [3]
12007-02-2 [3]
234-495-1 [3]
Nickel boride [4]
12619-90-8 [4]
235-723-2 [4]
Dinickel silicide [5]
12059-14-2 [5]
235-033-1 [5]
Nickel disilicide [6]
12201-89-7 [6]
235-379-3 [6]
Dinickel phosphide [7]
12035-64-2 [7]
234-828-0 [7]
Nickel boron phosphide [8]
65229-23-4 [8]
— [8]
1463
Dialuminium nickel tetraoxide [1]
12004-35-2 [1]
234-454-8 [1]
Nickel titanium trioxide [2]
12035-39-1 [2]
234-825-4 [2]
Nickel titanium oxide [3]
12653-76-8 [3]
235-752-0 [3]
Nickel divanadium hexaoxide [4]
52502-12-2 [4]
257-970-5 [4]
Cobalt dimolybdenum nickel octaoxide [5]
68016-03-5 [5]
268-169-5 [5]
Nickel zirkonium trioxide [6]
70692-93-2 [6]
274-755-1 [6]
Molybdenum nickel tetraoxide [7]
14177-55-0 [7]
238-034-5 [7]
Nickel tungsten tetraoxide [8]
14177-51-6 [8]
238-032-4 [8]
Olivine, nickel green [9]
68515-84-4 [9]
271-112-7 [9]
Lithium nickel dioxide [10]
12031-65-1 [10]
620-400-4 [10]
Molybdenum nickel oxide [11]
12673-58-4 [11]
— [11]
1464
Cobalt lithium nickel oxide
—
442-750-5
1465
Molybdenum trioxide
1313-27-5
215-204-7
1466
Dibutyltin dichloride; (DBTC)
683-18-1
211-670-0
1467
4,4′-Bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane
151882-81-4
418-770-5
1468
Furfuryl alcohol
98-00-0
202-626-1
1469
1,2-Epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide
106-87-6
203-437-7
1470
6-Glycidyloxynapht-1-yl oxymethyloxirane
27610-48-6
429-960-2
1471
2-(2-Aminoethylamino)ethanol; (AEEA)
111-41-1
203-867-5
1472
1,2-Diethoxyethane
629-14-1
211-076-1
1473
2,3-Epoxypropyltrimethylammonium chloride; glycidyl trimethylammonium chloride
3033-77-0
221-221-0
1474
1-(2-Amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride
214353-17-0
433-580-2
1475
(E)-3-[1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
82413-20-5
428-010-4
1476
4,4′-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol
13595-25-0
428-970-4
1477
2-Chloro-6-fluoro-phenol
2040-90-6
433-890-8
1478
2-Methyl-5-tert-butylthiophenol
—
444-970-7
1479
2-Butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one
94723-86-1
425-150-8
1480
Profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one
139001-49-3
604-105-8
1481
Tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one
149979-41-9
604-715-4
1482
Cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione
5571-36-8
427-230-8
1483
Androsta-1,4,9(11)-triene-3,17-dione
15375-21-0
433-560-3
1484
Reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates (branched C10-14 and C18-30 alkylated)
—
415-930-6
1485
1,2-Benzenedicarboxylic acid; di-C6-8-branched alkylesters, C7-rich
71888-89-6
276-158-1
1486
Reaction mass of: diester of 4,4′-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2); triester of 4,4′-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)
—
427-140-9
1487
Diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate
150202-11-2
422-670-7
1488
3-Oxoandrost-4-ene-17-β-carboxylic acid
302-97-6
414-990-0
1489
(Z)-2-Methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid
64485-90-1
431-520-1
1490
Trisodium nitrilotriacetate
5064-31-3
225-768-6
1491
2-Ethylhexyl-2-ethylhexanoate
7425-14-1
231-057-1
1492
Diisobutyl phthalate
84-69-5
201-553-2
1493
Perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid [1]
1763-23-1 [1]
217-179-8 [1]
Potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate [2]
2795-39-3 [2]
220-527-1 [2]
Diethanolamine perfluorooctane sulfonate [3]
70225-14-8 [3]
274-460-8 [3]
Ammonium perfluorooctane sulfonate; ammonium heptadecafluorooctanesulfonate [4]
29081-56-9 [4]
249-415-0 [4]
Lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate [5]
29457-72-5 [5]
249-644-6 [5]
1494
Ethyl 1-(2,4-dichlorophenyl)5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate
103112-35-2
401-290-5
1495
1-Bromo-2-methylpropyl propionate
158894-67-8
422-900-6
1496
Chloro-1-ethylcyclohexyl carbonate
99464-83-2
444-950-8
1497
6,6′-Bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)
—
441-550-5
1498
Trifluralin (ISO); α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine; 2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline; N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline
1582-09-8
216-428-8
1499
4-Mesyl-2-nitrotoluene
1671-49-4
430-550-0
1500
Triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate
221354-37-6
432-270-4
1501
Reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate
163879-69-4
438-310-7
1502
N,N′-Diacetylbenzidine
613-35-4
210-338-2
1503
Cyclohexylamine
108-91-8
203-629-0
1504
Piperazine
110-85-0
203-808-3
1505
Hydroxylamine
7803-49-8
232-259-2
1506
Hydroxylammonium chloride; hydroxylamine hydrochloride [1]
5470-11-1 [1]
226-798-2 [1]
Bis(hydroxylammonium) sulfate; hydroxylamine sulfate (2:1) [2]
10039-54-0 [2]
233-118-8 [2]
1507
Methyl-phenylene diamine; diaminotoluene
—
—
1508
Mepanipyrim; 4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine
110235-47-7
600-951-7
1509
Hydroxylammonium hydrogensulfate; hydroxylamine sulfate(1:1) [1]
10046-00-1 [1]
233-154-4 [1]
Hydroxylamine phosphate [2]
20845-01-6 [2]
244-077-0 [2]
Hydroxylamine dihydrogenphosphate [3]
19098-16-9 [3]
242-818-2 [3]
Hydroxylamine 4-methylbenzenesulfonate [4]
53933-48-5 [4]
258-872-5 [4]
1510
(3-Chloro-2-hydroxypropyl) trimethylammonium chloride
3327-22-8
222-048-3
1511
Biphenyl-3,3′,4,4′-tetrayltetraamine; diaminobenzidine
91-95-2
202-110-6
1512
Piperazine hydrochloride [1]
6094-40-2 [1]
228-042-7 [1]
Piperazine dihydrochloride [2]
142-64-3 [2]
205-551-2 [2]
Piperazine phosphate [3]
1951-97-9 [3]
217-775-8 [3]
1513
3-(Piperazin-1-yl)-benzo[d]isothiazole hydrochloride
87691-88-1
421-310-6
1514
2-Ethylphenylhydrazine hydrochloride
19398-06-2
421-460-2
1515
(2-Chloroethyl)(3-hydroxypropyl)ammonium chloride
40722-80-3
429-740-6
1516
4-[(3-Chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride
159939-85-2
425-030-5
1517
Chloro-N,N-dimethylformiminium chloride
3724-43-4
425-970-6
1518
7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one
199327-61-2
429-400-7
1519
Reaction products of diisopropanolamine with formaldehyde (1:4)
220444-73-5
432-440-8
1520
3-Chloro-4-(3-fluorobenzyloxy)aniline
202197-26-0
445-590-4
1521
Ethidium bromide; 3,8-diamino-1-ethyl-6-phenylphenantridinium bromide
1239-45-8
214-984-6
1522
(R,S)-2-Amino-3,3-dimethylbutane amide
144177-62-8
447-860-7
1523
3-Amino-9-ethyl carbazole; 9-ethylcarbazol-3-ylamine
132-32-1
205-057-7
1524
(6R-trans)-1-((7-Ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide
100988-63-4
423-260-0
1525
Forchlorfenuron (ISO); 1-(2-chloro-4-pyridyl)-3-phenylurea
68157-60-8
614-346-0
1526
Tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one; dimethyl propyleneurea
7226-23-5
230-625-6
1527
Quinoline
91-22-5
202-051-6
1528
Ketoconazole; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
65277-42-1
265-667-4
1529
Metconazole (ISO); (1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol
125116-23-6
603-031-3
1530
Potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate
183196-57-8
418-260-2
1531
N,N′,N′-Tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine
26157-73-3
435-010-8
1532
Trimethylopropane tri(3-aziridinylpropanoate); (TAZ)
52234-82-9
257-765-0
1533
4,4′-Methylenediphenyl diisocyanate; diphenylmethane-4,4′-diisocyanate [1]
101-68-8 [1]
202-966-0 [1]
2,2′-Methylenediphenyl diisocyanate; diphenylmethane-2,2′-diisocyanate [2]
2536-05-2 [2]
219-799-4 [2]
o-(p-Isocyanatobenzyl)phenyl isocyanate; diphenylmethane-2,4′-diisocyanate [3]
5873-54-1 [3]
227-534-9 [3]
Methylenediphenyl diisocyanate [4]
26447-40-5 [4]
247-714-0 [4]
1534
Cinidon ethyl (ISO); ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate
142891-20-1
604-318-6
1535
N-[6,9-Dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide
84245-12-5
424-550-1
1536
Dimoxystrobin (ISO); (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide
149961-52-4
604-712-8
1537
N,N-(Dimethylamino)thioacetamide hydrochloride
27366-72-9
435-470-1
1538
Reaction mass of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide; 2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide; 2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′- biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3- oxo-butanamide
434-330-5
1539
Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or other processing methods if they contain ≥ 0,1 % w/w benzene
85536-20-5
85536-19-2
90641-12-6
90989-38-1
91995-20-9
92062-36-7
91995-61-8
101316-63-6
93821-38-6
90641-02-4
101316-62-5
90641-03-5
65996-79-4
101794-90-5
90640-87-2
84650-03-3
65996-82-9
90641-01-3
65996-87-4
90640-99-6
68391-11-7
92062-33-4
91082-52-9
68937-63-3
92062-28-7
92062-27-6
91082-53-0
91995-31-2
91995-35-6
91995-66-3
122070-79-5
122070-80-8
65996-78-3
94114-52-0
94114-53-1
94114-54-2
94114-56-4
94114-57-5
90641-11-5
8006-61-9
8030-30-6
8032-32-4
64741-41-9
64741-42-0
64741-46-4
64742-89-8
68410-05-9
68514-15-8
68606-11-1
68783-12-0
68921-08-4
101631-20-3
64741-64-6
64741-65-7
64741-66-8
64741-70-4
64741-84-0
64741-92-0
68410-71-9
68425-35-4
68527-27-5
91995-53-8
92045-49-3
92045-55-1
92045-58-4
92045-64-2
101316-67-0
64741-54-4
64741-55-5
68476-46-0
68783-09-5
91995-50-5
92045-50-6
92045-59-5
92128-94-4
101794-97-2
101896-28-0
64741-63-5
64741-68-0
68475-79-6
68476-47-1
68478-15-9
68513-03-1
68513-63-3
68514-79-4
68919-37-9
68955-35-1
85116-58-1
91995-18-5
93571-75-6
93572-29-3
93572-35-1
93572-36-2
64741-74-8
64741-83-9
67891-79-6
67891-80-9
68425-29-6
68475-70-7
68603-00-9
68603-01-0
68603-03-2
68955-29-3
92045-65-3
64742-48-9
64742-49-0
64742-73-0
68410-96-8
68410-97-9
68410-98-0
68512-78-7
85116-60-5
85116-61-6
92045-51-7
92045-52-8
92045-57-3
92045-61-9
92062-15-2
93165-55-0
93763-33-8
93763-34-9
64741-47-5
64741-48-6
64741-69-1
64741-78-2
64741-87-3
64742-15-0
64742-22-9
64742-23-0
64742-66-1
64742-83-2
64742-95-6
68131-49-7
68477-34-9
68477-50-9
68477-53-2
68477-55-4
68477-61-2
68477-89-4
68478-12-6
68478-16-0
68513-02-0
68516-20-1
68527-21-9
68527-22-0
68527-23-1
68527-26-4
68603-08-7
68606-10-0
68783-66-4
68919-39-1
68921-09-5
85116-59-2
86290-81-5
90989-42-7
91995-38-9
91995-41-4
91995-68-5
92045-53-9
92045-60-8
92045-62-0
92045-63-1
92201-97-3
93165-19-6
94114-03-1
95009-23-7
97926-43-7
98219-46-6
98219-47-7
101316-56-7
101316-66-9
101316-76-1
101795-01-1
102110-14-5
68476-50-6
68476-55-1
90989-39-2
287-502-5
287-500-4
292-636-2
292-694-9
295-281-1
295-551-9
295-323-9
309-868-8
298-725-2
292-625-2
309-867-2
292-626-8
266-013-0
309-971-8
292-609-5
283-483-2
266-016-7
292-624-7
266-021-4
292-622-6
269-929-9
295-548-2
293-766-2
273-077-3
295-543-5
295-541-4
293-767-8
295-292-1
295-295-8
295-329-1
310-170-0
310-171-6
266-012-5
302-688-0
302-689-6
302-690-1
302-692-2
302-693-8
292-635-7
232-349-1
232-443-2
232-453-7
265-041-0
265-042-6
265-046-8
265-192-2
270-077-5
271-025-4
271-727-0
272-186-3
272-931-2
309-945-6
265-066-7
265-067-2
265-068-8
265-073-5
265-086-6
265-095-5
270-088-5
270-349-3
271-267-0
295-315-5
295-430-0
295-436-3
295-440-5
295-446-8
309-871-4
265-055-7
265-056-2
270-686-6
272-185-8
295-311-3
295-431-6
295-441-0
295-794-0
309-974-4
309-987-5
265-065-1
265-070-9
270-660-4
270-687-1
270-794-3
270-993-5
271-008-1
271-058-4
272-895-8
273-271-8
285-509-8
295-279-0
297-401-8
297-458-9
297-465-7
297-466-2
265-075-6
265-085-0
267-563-4
267-565-5
270-344-6
270-658-3
271-631-9
271-632-4
271-634-5
273-266-0
295-447-3
265-150-3
265-151-9
265-178-6
270-092-7
270-093-2
270-094-8
270-988-8
285-511-9
285-512-4
295-432-1
295-433-7
295-438-4
295-443-1
295-529-9
296-942-7
297-852-0
297-853-6
265-047-3
265-048-9
265-071-4
265-079-8
265-089-2
265-115-2
265-122-0
265-123-6
265-170-2
265-187-5
265-199-0
268-618-5
270-725-7
270-735-1
270-736-7
270-738-8
270-741-4
270-771-8
270-791-7
270-795-9
270-991-4
271-138-9
271-262-3
271-263-9
271-264-4
271-266-5
271-635-0
271-726-5
272-206-0
272-896-3
272-932-8
285-510-3
289-220-8
292-698-0
295-298-4
295-302-4
295-331-2
295-434-2
295-442-6
295-444-7
295-445-2
296-028-8
296-903-4
302-639-3
305-750-5
308-261-5
308-713-1
308-714-7
309-862-5
309-870-9
309-879-8
309-976-5
310-012-0
270-690-8
270-695-5
292-695-4
1540
Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or other processing methods if they contain ≥ 0,005 % w/w benzo[a]pyrene
90640-85-0
92061-93-3
90640-84-9
61789-28-4
70321-79-8
122384-77-4
70321-80-1
292-606-9
295-506-3
292-605-3
263-047-8
274-565-9
310-189-4
274-566-4
1541
Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or other processing methods if they contain ≥ 0,1 % w/w benzene or if they contain ≥ 0,005 % w/w benzo[a]pyrene
85029-51-2
84650-04-4
84989-09-3
91995-49-2
121620-47-1
121620-48-2
90640-90-7
90641-04-6
101896-27-9
101794-91-6
91995-48-1
90641-05-7
84989-12-8
121620-46-0
90640-81-6
90640-82-7
92061-92-2
91995-15-2
91995-16-3
91995-17-4
101316-87-4
122384-78-5
84988-93-2
90640-88-3
65996-83-0
90640-89-4
90641-06-8
65996-85-2
101316-86-3
92062-22-1
96690-55-0
84989-04-8
84989-05-9
84989-06-0
84989-03-7
84989-07-1
68477-23-6
68555-24-8
91079-47-9
92062-26-5
94114-29-1
90641-00-2
68513-87-1
70321-67-4
92062-29-8
100801-63-6
100801-65-8
100801-66-9
73665-18-6
68815-21-4
65996-86-3
65996-84-1
285-076-5
283-484-8
284-898-1
295-310-8
310-166-9
310-167-4
292-612-1
292-627-3
309-985-4
309-972-3
295-309-2
292-628-9
284-901-6
310-165-3
292-603-2
292-604-8
295-505-8
295-275-9
295-276-4
295-278-5
309-889-2
310-191-5
284-881-9
292-610-0
266-017-2
292-611-6
292-629-4
266-019-3
309-888-7
295-536-7
306-251-5
284-892-9
284-893-4
284-895-5
284-891-3
284-896-0
270-713-1
271-418-0
293-435-2
295-540-9
302-662-9
292-623-1
271-020-7
274-560-1
295-544-0
309-745-9
309-748-5
309-749-0
277-567-8
272-361-4
266-020-9
266-018-8
1542
Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or other processing methods if they contain ≥ 0,1 % w/w 1,3-butadiene
68607-11-4
68783-06-2
68814-67-5
68814-90-4
68911-58-0
68911-59-1
68919-01-7
68919-02-8
68919-03-9
68919-04-0
68919-07-3
68919-08-4
68919-11-9
68919-12-0
68952-79-4
68952-80-7
68955-33-9
68989-88-8
92045-15-3
92045-16-4
92045-17-5
92045-18-6
92045-19-7
92045-20-0
68131-75-9
68307-98-2
68307-99-3
68308-00-9
68308-01-0
68308-10-1
68308-03-2
68308-04-3
68308-05-4
68308-06-5
68308-07-6
68308-09-8
68308-11-2
68308-12-3
68409-99-4
68475-57-0
68475-58-1
68475-59-2
68475-60-5
68476-26-6
68476-29-9
68476-40-4
68476-42-6
68476-49-3
68476-85-7
68476-86-8
68477-33-8
68477-35-0
68477-69-0
68477-70-3
68477-71-4
68477-72-5
68308-08-7
271-750-6
272-182-1
272-338-9
272-343-6
272-775-5
272-776-0
272-873-8
272-874-3
272-875-9
272-876-4
272-880-6
272-881-1
272-884-8
272-885-3
273-173-5
273-174-0
273-269-7
273-563-5
295-397-2
295-398-8
295-399-3
295-400-7
295-401-2
295-402-8
268-629-5
269-617-2
269-618-8
269-619-3
269-620-9
269-630-3
269-623-5
269-624-0
269-625-6
269-626-1
269-627-7
269-629-8
269-631-9
269-632-4
270-071-2
270-651-5
270-652-0
270-653-6
270-654-1
270-667-2
270-670-9
270-681-9
270-682-4
270-689-2
270-704-2
270-705-8
270-724-1
270-726-2
270-750-3
270-751-9
270-752-4
270-754-5
269-628-2
1543
Tris[2-chloro-1-(chloromethyl)ethyl] phosphate
13674-87-8
237-159-2
1544
Indium phosphide
22398-80-7
244-959-5
1545
Trixylyl phosphate
25155-23-1
246-677-8
1546
Hexabromocyclododecane [1]
25637-99-4 [1]
247-148-4 [1]
1,2,5,6,9,10-Hexabromocyclododecane [2]
3194-55-6 [2]
221-695-9 [2]
1547
Tetrahydrofuran
109-99-9
203-726-8
1548
Abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]
71751-41-2 [1]
615-339-5 [1]
Avermectin B1a [2]
65195-55-3 [2]
265-610-3 [2]
1549
4-tert-Butylbenzoic acid
98-73-7
202-696-3
1550
Leucomalachite green; N,N,N′,N′-tetramethyl-4,4′-benzylidenedianiline
129-73-7
204-961-9
1551
Fuberidazole (ISO); 2-(2-furyl)-1H-benzimidazole
3878-19-1
223-404-0
1552
Metazachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide
67129-08-2
266-583-0
1553
Di-tert-butyl peroxide
110-05-4
203-733-6
1554
Trichloromethylstannane
993-16-8
213-608-8
1555
2-Ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
57583-34-3
260-828-5
1556
2-Ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
15571-58-1
239-622-4
1557
Sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione
99105-77-8
619-394-6
1558
Bifenthrin (ISO); (2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate
82657-04-3
617-373-6
1559
Dihexyl phthalate
84-75-3
201-559-5
1560
Ammonium pentadecafluorooctanoate
3825-26-1
223-320-4
1561
Perfluorooctanoic acid
335-67-1
206-397-9
1562
N-Ethyl-2-pyrrolidone; 1-ethylpyrrolidin-2-one
2687-91-4
220-250-6
1563
Proquinazid (ISO); 6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one
189278-12-4
606-168-7
1564
Gallium arsenide
1303-00-0
215-114-8
1565
Vinyl acetate
108-05-4
203-545-4
1566
Aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline
74070-46-5
277-704-1
1567
2-Ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
57583-35-4
260-829-0
1568
Dimethyltin dichloride
753-73-1
212-039-2
1569
4-Vinylcyclohexene
100-40-3
202-848-9
1570
Tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one
87820-88-0
618-075-9
1571
Cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one
101205-02-1
405-230-9
1572
Fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine
79622-59-6
616-712-5
1573
Penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole
66246-88-6
266-275-6
1574
Fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate
72490-01-8
276-696-7
1575
Styrene
100-42-5
202-851-5
1576
Tetrahydro-2-furylmethanol; tetrahydrofurfuryl alcohol
97-99-4
202-625-6
1577
Formaldehyde
50-00-0
200-001-8
1578
Paraformaldehyde
30525-89-4
608-494-5
1579
Methanediol; methylene glycol
463-57-0
207-339-5
1580
Cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide
57966-95-7
261-043-0
1581
Tributyltin compounds
—
—
1582
Tembotrione (ISO); 2-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dione
335104-84-2
608-879-8
1583
1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linear
68515-50-4
271-093-5
1584
Spirotetramat (ISO); (5s,8s)-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-yl ethyl carbonate
203313-25-1
606-523-6
1585
Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate
31717-87-0
250-778-2
1586
Triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6-(2,2,2- trifluoroethoxy)-1,3,5-triazin-2- yl]carbamoyl}sulfamoyl)-3- methylbenzoate
126535-15-7
603-146-9
1587
Imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
35554-44-0
252-615-0
1588
Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine
1593-77-7
216-474-9
1589
Imidazole
288-32-4
206-019-2
1590
Lenacil (ISO); 3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione
2164-08-1
218-499-0
1591
Metosulam (ISO); N-(2,6-dichloro-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide
139528-85-1
604-145-6
1592
2-Methyl-1-(4-methylthiophenyl)-2-morpholino-propan 1-one
71868-10-5
400-600-6
1593
2,3-Epoxypropyl methacrylate; glycidyl methacrylate
106-91-2
203-441-9
1594
Spiroxamine (ISO); 8-tert-butyl-1,4-dioxaspirol[4.5]decan-2-ylmethyl(ethyl)(propyl)amine
118134-30-8
601-505-4
1595
Cyanamide; carbanonitril
420-04-2
206-992-3
1596
Cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
94361-06-5
619-020-1
1597
Silver zinc zeolite
130328-20-0
603-404-0
1598
Cadmium carbonate
513-78-0
208-168-9
1599
Cadmium hydroxide; cadmium dihydroxide
21041-95-2
244-168-5
1600
Cadmium nitrate; cadmium dinitrate
10325-94-7
233-710-6
1601
Dibutyltin dilaurate; dibutyl[bis(dodecanoyloxy)] stannane
77-58-7
201-039-8
1602
Clorofene; chlorophene; 2-benzyl-4-chlorophenol
120-32-1
204-385-8
1603
Anthraquinone
84-65-1
201-549-0
1604
Nonadecafluorodecanoic acid [1]
335-76-2 [1]
206-400-3[1]
Ammonium nonadecafluorodecanoate [2]
3108-42-7 [2]
221-470-5 [2] [3]
Sodium nonadecafluorodecanoate [3]
3830-45-3 [3]
1605
N,N′-Methylenedimorpholine; N,N′-methylenebismorpholine; [formaldehyde released from N,N′-Methylenebismorpholine]; [MBM]
if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is ≥ 0,1 % w/w
5625-90-1
227-062-3
1606
Reaction products of paraformaldehyde with 2-hydroxypropylamine (3:2); [formaldehyde released from 3,3′-methylenebis[5–methyloxazolidine]; [formaldehyde released from oxazolidin]; [MBO]
if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is ≥ 0,1 % w/w
—
—
1607
Reaction products of paraformaldehyde with 2-hydroxypropylamine (1:1)); [formaldehyde released from α,α,α-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol]; [HPT]
if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is ≥ 0,1 % w/w
—
—
1608
Methylhydrazine
60-34-4
200-471-4
1609
Triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; α-tert-butyl-β-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol
55219-65-3
259-537-6
1610
Thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridyl-methyl)-1-3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide
111988-49-9
601-147-9
1611
Carbetamide (ISO); (R)-1-(ethylcarbamoyl) ethyl-carbanilate; (2R)-1-(ethylamino) -1-oxopro-pan-2-yl-phenylcarbamate
16118-49-3
240-286-6’
- (b)
entry 395 is replaced by the following:
Reference number
Substance identification
Chemical name/INN
CAS number
EC number
‘395
Hydroxy-8-quinoline and its sulphate
148-24-2
134-31-6
205-711-1
205-137-1’
(2)Annex III is amended as follows:
- (a)
entries 1a, 1b, 7, 13 and 51 are deleted;
- (b)
entry 12 is replaced by the following;
Reference number
Substance identification
Restrictions
Wording of conditions of use and warnings
Chemical name/INN
Name of Common Ingredients Glossary
CAS number
EC number
Product type, body parts
Maximum concentration in ready for use preparation
Other
a
b
c
d
e
f
g
h
i
‘12
Hydrogen peroxide and other compounds or mixtures that release hydrogen peroxide, including carbamide peroxide and zinc peroxide, with the exception of the following substances in Annex II:
No 1397, 1398, 1399
Hydrogen peroxide
7722-84-1
231-765-0
(a)
Hair products
(a)
12 % of H2O2 (40 volumes), present or released
(a) (f) Wear suitable gloves
(a) (b) (c) (e)
Contains hydrogen peroxide
Avoid contact with eyes
Rinse immediately if product comes into contact with them.
(b)
Skin products
(b)
4 % of H2O2, present or released
(c)
Nail hardening products
(c)
2 % of H2O2, present or released
(d)
Oral products, including mouth rinse, tooth paste and tooth whitening or bleaching products
(d)
≤ 0,1 % of H2O2, present or released
(e)
Tooth whitening or bleaching products
(e)
> 0,1 % ≤ 6 % of H2O2, present or released
(e)To be only sold to dental practitioners. For each cycle of use, first use by dental practitioners as defined under Directive 2005/36/EC of the European Parliament and of the Council21 or under their direct supervision if an equivalent level of safety is ensured.
Afterwards to be provided to the consumer to complete the cycle of use.
Not to be used on a person under 18 years of age.
(e)Concentration of H2O2 present or released indicated in percentage.
Not to be used on a person under 18 years of age.
To be only sold to dental practitioners. For each cycle of use, the first use to be only done by dental practitioners or under their direct supervision if an equivalent level of safety is ensured.
Afterwards to be provided to the consumer to complete the cycle of use.
(f)
Products intended for eyelashes
(f)
2 % of H2O2, present or released
(f)
For professional use only
f)To be printed on the label:
For professional use only.
Avoid contact with eyes.
Rinse eyes immediately if product comes into contact with them.
Contains hydrogen peroxide
Directive 2005/36/EC of the European Parliament and of the Council of 7 September 2005 on the recognition of professional qualifications (OJ L 255, 30.9.2005, p. 22).’;
- (c)
the following entries are added:
Ref No.
Substance identification
Restrictions
Wording of conditions of use and warnings
Chemical name/INN
Name of Common Ingredients Glossary
CAS number
EC number
Product type, body parts
Maximum concentration in ready for use preparation
Other
a
b
c
d
e
f
g
h
i
‘311
Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide
Trimethylbenzoyl diphenylphosphine oxide
75980-60-8
278-355-8
Artificial nail systems
5,0 %
Professional use
For professional use only
Avoid skin contact
Read directions for use carefully
312
2-Furaldehyde
Furfural
98-01-1
202-627-7
0,001 %’
(3)Annex V is amended as follows:
- (a)
point 2 of the preamble is replaced by the following:
2.
All finished products containing substances in this Annex and which release formaldehyde must be labelled with the warning ‘contains formaldehyde’ where the concentration of formaldehyde in the finished product exceeds 0,05 %
- (b)
entries 5, 31, 40 and 41 are deleted;
- (c)
entry 28 is replaced by the following:
Reference number
Substance Identification
Conditions
Wording of conditions of use and warnings
Chemical name/INN
Name of Common Ingredients Glossary
CAS number
EC number
Product type, Body parts
Maximum concentration in ready for use preparation
Other
a
b
c
d
e
f
g
h
i
‘28
Polyhexamethylene biguanide hydrochloride
Polyaminopropyl biguanide
32289-58-0,
27083-27-8,
28757-47-3,
133029-32-0
608-723-9
608-042-7
0,1 %
Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation’